Bolt Bio Adds Mayo Clinic’s Edith Perez as Chief Medical Officer

Bolt Biotherapeutics has added longtime Mayo Clinic professor Edith Perez to its C-suite as chief medical officer. Perez, who has taught at Mayo for two decades and heads its Breast Cancer Translational Genomics program, will maintain a clinical affiliation. She previously served another stint in industry, spending three years as head of US medical affairs for Genentech’s BioOncology unit.

Redwood City, CA-based Bolt is developing cancer drugs that deploy a tumor-targeting antibody that homes in on tumors paired with an immune stimulant that turns “cold” tumors—those the immune system doesn’t recognize or respond to—“hot.” Last year, Bolt raised $54 million in a Series B round of financing.

Author: Sarah de Crescenzo

Sarah is Xconomy's San Diego-based editor. Prior to joining the team in 2018, she wrote about startups, tech and finance at the San Diego Business Journal. Her decade of full-time news experience includes coverage of subjects including campaign finance, crime and courts as a reporter and editor at outlets throughout California, including the Orange County Register. She earned a bachelor's degree in English Literature at UC San Diego, where she wrote for the student newspaper and played collegiate lacrosse. In 2019, she earned an MBA at UC Irvine.